Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Actelion

Clinical trials sponsored by Actelion, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

A pharmaceutical company focused on pulmonary hypertension, now part of Johnson & Johnson.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 4 Completed 8

New study tracks Long-Term safety of two common PH drugs

Disease control Recruiting now

This study follows 280 adults and children with pulmonary hypertension who are already taking macitentan or selexipag in a previous trial. The goal is to monitor long-term safety, including side effects and serious events, while allowing continued access to the medication. Partic…

Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC